<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15011">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02911454</url>
  </required_header>
  <id_info>
    <org_study_id>EBB15YE89845</org_study_id>
    <nct_id>NCT02911454</nct_id>
  </id_info>
  <brief_title>Assess the Effects of Infant Formula on Infant Stool Characteristics, Behaviour and Parental Experience in Everyday Situations</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia Research</source>
  <brief_summary>
    <textblock>
      A prospective, multi-country, open label study to describe the stool characteristics and
      behaviour as well as the parents' experience in infants receiving a recently launched infant
      formula in a real life situation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool consistency measured by Amsterdam Stool Scale.</measure>
    <time_frame>15 months</time_frame>
    <description>Will be reported in diaries completed by the parents.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Crying time</measure>
    <time_frame>15 months</time_frame>
    <description>Will be reported in diaries completed by the parents.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool frequency</measure>
    <time_frame>15 months</time_frame>
    <description>Will be reported in diaries completed by the parents.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eating behaviour</measure>
    <time_frame>15 months</time_frame>
    <description>Baby Eating Behaviour Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental experience of child behaviour</measure>
    <time_frame>15 months</time_frame>
    <description>PedsQL,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on family life</measure>
    <time_frame>15 months</time_frame>
    <description>FamPedsQL</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Healthy infants: fully or partly formula fed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Infant formula</intervention_name>
    <arm_group_label>Healthy infants: fully or partly formula fed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy term infants, gestational age up to and including 37 weeks and 42 weeks and
             below. Healthy is defined as &quot;no supervision or medical treatment by a medical
             specialist. Further more to be determined by HCP.

          -  Birth weight between 2.5 - 4.5 KG (within normal range for gestational age and sex)

          -  Infants up to 6 weeks of postnatal age (Including day 42)

          -  Receiving exclusively or at least 1 complete infant formula feeding per day at study
             inclusion (retrospectively exclusively or partly formula fed)

          -  Willingness to change from their regular infant formula to study product

          -  Parents' or legal guardians' aged up to and including 18 years, written, informed
             consent.

        Exclusion Criteria:

          -  Infants with a congenital condition and / or previous or current illness and (or)
             medication that could interfere with the study

          -  Infants with established or suspected cows milk allergy, lactose intolerance,
             galactosaemia or infants on a prescribed fibre free (e.g. prebiotic oligosaccharides)
             diet

          -  Participation in any other studies involving investigational or marketed products
             concomitantly or within 2 weeks prior to entry into the study

          -  Investigator's uncertainty about the willingness of the parents / legal guardians to
             comply with the protocol requirements.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Namkje van der Laan, PhD</last_name>
    <phone>+31 30 209 5000</phone>
    <email>Namkje.vanderlaan@danone.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Private practice</name>
      <address>
        <city>Bischofshofen</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Scholtze, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Matthias Scholtze, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private practice</name>
      <address>
        <city>Eferding</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Neugebauer, MD</last_name>
    </contact>
    <investigator>
      <last_name>Johannes Neugebauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private practice</name>
      <address>
        <city>Hallein</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernst Wenger, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Ernst Wenger, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private practice</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Kahr, MD</last_name>
    </contact>
    <investigator>
      <last_name>Peter Kahr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private practice</name>
      <address>
        <city>Salzburg</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Drexler, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Roland Drexler, Dr. Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reinhold Rauscher</name>
      <address>
        <city>Salzburg</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reinhold Rauscher, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Reinhold Rauscher, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Poliklinika Ginekologiczno-Poloznicza Sp. Z.O.O Sp.K</name>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Promed</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Sağlık Bilimleri Üniversitesi Ankara Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hatice Tatar, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hatice Tatar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uludağ Üniversitesi Tıp Fakültesi</name>
      <address>
        <city>Bursa</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hilal Özkan, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hilal Özkan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haseki Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Demet Oğuz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Demet Oğuz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istanbul Florence Nightingale Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ozan Uzunhan, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ozan Uzunhan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medipol Mega Üniversite Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fatma Gamze Demirel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fatma Gamze Demirel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sağlık Bilimleri Üniversitesi Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Merih Çetinkaya, MD</last_name>
    </contact>
    <investigator>
      <last_name>Merih Çetinkaya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sağlık Bilimleri Üniversitesi Süleymaniye Kadın Doğum ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serdar Cömert, MD</last_name>
    </contact>
    <investigator>
      <last_name>Serdat Cömert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sağlık Bilimleri Üniversitesi Ümraniye Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leyla Karadeniz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Leyla Karadeniz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Poland</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 20, 2017</lastchanged_date>
  <firstreceived_date>August 30, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
